Search

In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.

MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...